Dara Pharma Showcases Its Aseptic Packaging Solutions at CIPM China 2026

Dara Pharma's participation in CIPM China 2026, held from October 27 to 29 in Xiamen, enabled us to strengthen our visibility at one of Asia's leading pharmaceutical industry events and connect with professionals interested in advanced technologies for pharmaceutical manufacturing and packaging.

Together with our partner Jerempli Co., Ltd., we were present at booth 3-B46, where we showcased our solutions for a wide range of pharmaceutical formats, as well as our capabilities in containment systems and lyophilization technologies.

Throughout the three-day exhibition, we held meetings with pharmaceutical manufacturers, production managers, and technical specialists interested in optimizing their processes, improving operational safety, and ensuring the highest quality standards within their facilities.

Visitors had the opportunity to discover our solutions for different pharmaceutical formats and explore the advantages of our technologies, which are designed to deliver greater flexibility, reliability, and efficiency in manufacturing processes. In addition, our containment systems and lyophilization equipment attracted significant interest from companies seeking to meet the industry's increasing regulatory and production requirements.

Once again, CIPM China proved to be a strategic meeting point for pharmaceutical industry professionals, fostering knowledge exchange and creating new opportunities for collaboration in one of the world's most dynamic markets.

Following our participation in CIPM China 2026, we continue to strengthen our presence in key international markets and reaffirm our commitment to developing innovative technologies for aseptic packaging and advanced pharmaceutical manufacturing.

At Dara Pharma, we would like to thank all the professionals who visited our booth and shared their projects and requirements with us. We look forward to building new opportunities for collaboration and supporting them in their future pharmaceutical manufacturing challenges.